Navigation Links
Potential new strategy to reduce catheter blockage
Date:4/12/2011

Bacterial genes that make urine less acidic could be good targets to prevent catheter blockage, according to research presented at the Society for General Microbiology's Spring Conference in Harrogate. The findings could lead to new strategies to prevent serious infections, particularly in long-term catheterization patients.

Urinary catheters are devices used in hospitals and community care homes to manage a range of bladder conditions, and are commonly used to manage incontinence in elderly individuals for long periods of time. Scientists from the University of Brighton, led by Dr Brian Jones, are looking at the bacterium Proteus mirabilis - a common cause of urinary tract infections in patients undergoing long-term catheterization, which often leads to serious complications.

P. mirabilis cells can stick together on catheter surfaces where they form highly organized communities called biofilms. As the bacterium breaks down urea (using the enzyme urease) it causes the pH of urine to rise, leading to the formation of insoluble crystals which become trapped in the growing biofilm. The crystalline deposits can form a crust on the catheter and may eventually block urine flow from the bladder. If unnoticed, catheter blockage can lead to kidney and bloodstream infections, which ultimately may result in potentially fatal septic shock.

The team is identifying genes involved in P. mirabilis biofilm formation, and assessing their contribution to catheter blockage. The results show that biofilm-forming ability may be less important to catheter blockage than previously thought, and suggest that inhibiting the rise in urinary pH is a primary target for preventing catheter blockage. Nina Holling who is carrying out the research said, "In our experiments we have found biofilm-forming ability not to be the most important factor in catheter blockage. Although biofilm formation does play a role, the ability of P. mirabilis to increase urinary pH and form crystals seems to compensate for deficiencies in biofilm formation. However, much more work is required to fully understand the progression of these infections and biofilm formation may be more important in the early stages of infection."

Ms Holling explained the significance of the team's work. "Long-term catheterization is linked with an increased mortality rate among nursing home patients, and effective strategies to control these infections are urgently required," she said. "A greater understanding of how P. mirabilis forms biofilms and behaves within them will be important in developing such strategies. In the longer term, this would greatly benefit patients undergoing long-term catheterization by eliminating painful recurrent infections, which greatly reduce quality of life. In addition, the financial savings to the NHS would be significant."


'/>"/>

Contact: Laura Udakis
l.udakis@sgm.ac.uk
44-118-988-1843
Society for General Microbiology
Source:Eurekalert  

Related medicine news :

1. New potential atherosclerosis risk marker discovered
2. New drug shows potential for treatment-resistant leukemia
3. Scientists find potential benefit of hypericin for recurrent brain tumors
4. Study Probes Potential Link Between Welding, Parkinsons Disease
5. Researchers mimic bodys own healing potential to create personalised therapies for inflammation
6. U-M scientists find potential driver of some aggressive prostate cancers
7. Heart drug cuts prostate cancer risk; holds potential for therapeutic use
8. For potentially crippling dystonia, earlier deep brain therapy gets better, quicker results
9. In pilot study, screening detects potentially serious heart conditions in healthy children
10. New vaccine candidate shows strong potential to prevent highly contagious norovirus
11. Potential new treatment to reduce the burden of atherosclerosis in acute coronary syndrome patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Potential new strategy to reduce catheter blockage
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) sponsors ... on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, ... to helping service members that have been wounded in battle and their families. Venture ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
Breaking Medicine Technology: